TMCI Earnings Date: Nov 6, 2026 (Estimated) — Treace Medical Concepts, Inc.
NASDAQ · Healthcare · Medical Devices
Updated
When is TMCI's next earnings date?
Treace Medical Concepts, Inc. (TMCI) is expected to report Q3 2026 earnings on Friday, November 6, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.26 on revenue of $47.8M.
How did TMCI do in its last earnings report?
In its most recent report on Aug 7, 2026 (Q2 2026), Treace Medical Concepts, Inc. posted EPS of -$0.24 versus the -$0.30 estimate, a beat of 20.0%. Revenue was $45.4M against a $44.0M estimate. The stock's 1-day post-earnings move was +8.7%.
How much does TMCI stock move after earnings?
TMCI beat EPS estimates in 6 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 12.6% (up or down) in the day after earnings.
About Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-07 | Q2 2026 | -0.30 | -0.24 | +20.00% | $45.4M | ✅ Beat | +8.68% | +2.97% | +9.82% |
| 2026-05-08 | Q1 2026 | -0.31 | -0.28 | +9.68% | $47.2M | ✅ Beat | +4.69% | +44.27% | +83.85% |
| 2026-02-27 | Q4 2025 | -0.14 | -0.15 | -7.14% | $62.5M | ❌ Miss | -11.43% | -33.81% | -41.90% |
| 2025-11-06 | Q3 2025 | -0.27 | -0.26 | +3.70% | $50.2M | ✅ Beat | -28.33% | -49.60% | -58.11% |
| 2025-08-07 | Q2 2025 | -0.29 | -0.28 | +3.45% | $47.4M | ✅ Beat | +7.92% | +22.36% | +25.18% |
| 2025-02-27 | Q4 2024 | -0.04 | -0.01 | +75.00% | $68.7M | ✅ Beat | -2.08% | -4.49% | -7.45% |
| 2024-11-05 | Q3 2024 | -0.27 | -0.25 | +7.41% | $45.1M | ✅ Beat | +35.07% | +39.58% | +34.55% |
| 2024-08-06 | Q2 2024 | -0.29 | -0.34 | -17.24% | $44.5M | ❌ Miss | -2.40% | -8.86% | -18.17% |
Showing last 8 quarters.